{
  "docId": "019de076-4f8b-70c9-adf8-0b3abb8c1303",
  "docSlug": "1af2d4156bf2490b3ac2801b5487abdf",
  "documentTitle": "Larimar Therapeutics | Investor Presentation Deck | 44 slides",
  "authorId": "larimar-therapeutics",
  "authorName": "Larimar Therapeutics",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 3,
  "pageCount": 44,
  "prevPage": 2,
  "nextPage": 4,
  "slideType": "executive_summary",
  "function": "summarize",
  "density": "balanced",
  "nDataPoints": 1,
  "notes": "The slide uses a list-based layout to present key company milestones and financial health.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-4f8b-70c9-adf8-0b3abb8c1303/3",
  "deckHref": "/decks/019de076-4f8b-70c9-adf8-0b3abb8c1303",
  "deckJsonHref": "/decks/019de076-4f8b-70c9-adf8-0b3abb8c1303.json",
  "deckAnchorHref": "/decks/019de076-4f8b-70c9-adf8-0b3abb8c1303#slide-3",
  "components": [
    {
      "bbox": {
        "h": 0.68,
        "w": 0.928,
        "x": 0.036,
        "y": 0.165
      },
      "kind": "list",
      "text": "Novel protein replacement therapy platform; Potential first-ever therapy to increase frataxin levels; Completed Phase 1 proof-of-concept; Phase 2 and OLE studies with near-term catalysts; Strong financial foundation",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "dc5e286b-2bed-4d25-af1c-f819758d5f28",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.1,
        "x": 0.25,
        "y": 0.77
      },
      "kind": "metric",
      "text": "$95.6 Million",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "96c15bc0-bb94-4c94-b916-11839a9f0c44",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.68,
        "x": 0.145,
        "y": 0.935
      },
      "kind": "source-note",
      "text": "*As of October 2023, nomlabofusp was published as the INN (International Proprietary Name) and USAN (United States Adopted Name) for CTI-1601",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "11a1337c-c50f-4fa5-9e1c-633288ef1dd5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.075,
        "w": 0.385,
        "x": 0.036,
        "y": 0.065
      },
      "kind": "title",
      "text": "Investment Highlights",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bed9b584-b7e9-4b25-b06d-31686eb13eed",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "AIDA Model",
      "slug": "aida-model",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "8ab245ee-fcf2-4afa-8371-986bb187099c",
      "evidence": "The slide follows the AIDA model by grabbing attention with 'Investment Highlights', providing interest by listing key points, and desire by highlighting the potential of the therapy.",
      "confidence": 0.7
    },
    {
      "name": "Executive summary",
      "slug": "executive-summary",
      "agent": null,
      "layer": "slide",
      "matchId": "75ab98d2-e3da-42d2-919f-baeeb3860ccb",
      "evidence": "This slide provides a high-level overview of the investment highlights, including a novel protein replacement therapy platform and strong financials.",
      "confidence": 0.9
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 3,
      "from": 3,
      "beatId": "eecc221a-f59e-4dc4-9762-a4322f3ac6c2",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Executive Summary",
      "beatSlug": null,
      "evidence": "A brief summary of investment highlights is provided on page 3",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}